Skip to content
drillr.ai
Sign up

603739.SH

Qingdao Vland Biotech, Inc.

SSE · Healthcare · Biotechnology · CN

CNY 12.05
−1.95%
Ask drillr

  • Sep 15, 2026, 09:17 UTC

    Vland Biotech announced that Qingying Granules, a jointly developed national class IV new veterinary drug, obtained a new veterinary drug registration certificate with a 3-year monitoring period.

    Source:

  • Aug 27, 2026, 08:09 UTC

    Weilan Biological released its 2026 first-half results, reporting revenue of 710 million yuan, up 8.80% year-on-year, and net profit attributable to shareholders of 38.56 million yuan, up 44.33%.

    Source: